Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
1:41, but you did not run spell check. ;)
Investor, it took you 3 minutes and 51 seconds to post your reply to falconer, whose post was not in reply to any of yours. So, do you have these retorts in a pipeline to quickly sort through and copy or are you able to read a post as it is being written?
To read, analyze and reply to that post so quickly is amazing ... unless you are the bot that many think frrol is ... or his twin bot.
Please provide said "single post."
Unfortunately, there are only 14 pages in this link, Doc.
Also, it is questionable how much assistance DPZ provides after 6 month or 26 weeks.
https://www.beingpatient.com/how-does-aricept-work-in-the-brain/#:~:text=Aricept%2C%20also%20known%20as%20Donezepil,usually%20for%20around%20six%20months.
I thought this remark is noteworthy:
FYI from Endpoints
Notable paragraph
https://endpts.com/new-alzheimers-drug-raises-hopes-along-with-questions/
bas, does Cramer join the smear campaign tonight?
AVXL Short Interest
SETTLEMENT DATE SHORT INTEREST AVG. DAILY SHARE VOLUME DAYS TO COVER
07/14/2023 16,728,610 623,329 26.837529
06/30/2023 16,739,768 1,148,109 14.580295
06/15/2023 17,739,562 1,165,885 15.215533
05/31/2023 16,508,942 763,358 21.626736
05/15/2023 15,901,191 937,267 16.965487
04/28/2023 14,379,183 798,137 18.015933
04/14/2023 15,594,970 981,502 15.888883
03/31/2023 15,887,617 1,275,882 12.452262
03/15/2023 15,677,855 1,171,753 13.379829
02/28/2023 16,320,041 850,227 19.194922
02/15/2023 17,125,449 1,160,761 14.753639
01/31/2023 16,719,384 1,128,968 14.80944
01/13/2023 18,368,256 1,504,154 12.211686
12/30/2022 18,252,546 1,422,909 12.827627
12/15/2022 15,780,885 7,073,260 2.231062
11/30/2022 11,914,762 1,787,726 6.664758
11/15/2022 10,167,456 986,389 10.307755
10/31/2022 10,105,713 985,598 10.253382
10/14/2022 10,043,451 718,819 13.972156
09/30/2022 10,260,594 936,366 10.957888
09/15/2022 9,737,900 683,304 14.251197
08/31/2022 9,102,975 706,411 12.886231
08/15/2022 8,428,105 784,854 10.738437
Thanks again, Moon ... hopefully, they haven't been in either of the last 3 administrations ... er, make it 5.
Thanks, Moon. I certainly get the impression that TGD believes Rett approval is as close as an NDA filing.
P.S. Who are KOLs?
george, how is T's post nonsense?
Many wait for your answer.
Thank you, raja. Nice to know your view is positive.
Peace
Sorry, for the initial truncated post.
Moon, how is this?
raja, while we wait for next week's call with Dr. Missling (emailed Clint, stating let it dynamic with words like "have done" rather than "will"), what is your view on Apple and today's release? Great, poor, strong forecast, not so good, etc.
TIA
So what gives with the Jan 2024 $12 call? 420 contracts traded ... positive or negative sign for s/holders?
I agree. I thought an underlying and unstated tone to the article was that amyloid thesis is losing its hold on researchers as Blacks and Hispanics are developing AD without the usual traits of plaque.
Thanks for posting, Investor. I was going to do it when I read it on the Reuters morning page.
P.S. You've had a busy morning.
Based on the original post, he wasn't correct! You can take back your "Like" if you'd like.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172467795
I know that but you did not based on your post to which I responded.
... and you can't give abe a "Like" after calling it
george, link does not work.
FYI, in case this is its first posting. Focus is on one of the favs here ... APOE e4 allele.
https://www.pressrundown.com/health/smell-loss-could-indicate-early-alzheimers-disease
Jared Whitlock
Features Editor
FYI - Pay wall exists.
https://endpts.com/this-is-not-a-science-problem-anymore-models-emerge-for-scaling-up-rare-disease-medicine/
pogue, if you read Endpoints and/or FierceBio, you would know that scores of pre-revenue bios have spiraled down to pennies or BK from the start of the pandemic.
Your account of bad, poor and incompetent management is not represented by facts but your own personal timetable that was not met and you are angry ... you have lots of company with mrp, .com et al.
Think the turtle and the hare. Who won?
You called it, not me. I'm only report some history for those asking the Board to act. I think it knows when to act.
pogue, you know the Board has the b*lls to move, if it needs to do so, as it threw out the previous CEO, Cameron Durrant, before he could lead it to BK-land.
See this post on the results of his current company, Humanigen.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172427959
Obviously, mrp, you haven't paid attention to Humanigen and its CEO, Cameron Durrant. He was Anavex's CEO before TGD. Too bad its board didn't act in a timely fashion as did Tom Skarpelos before Anavex went into BK.
Hot off this morning's news wire:
From Preciouslife 1 on iHub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172427959
go avxl, hopefully more than when Q3 cc is being held.
Investor, if you look at the percentages shown, the n used is 168 for the placebo and 335 for Anavex 2-73. For 2-73, there were 48 people who were not part of "up titration," so, they could not be "down titrated." [Is this a reasonable conclusion?]
Thus, those who were down titrated from the "Subjects Up Titrated to 30mg or 50mg n (%)" would be the 287 - 263 = 24, or 8.4%.
So, given your numbers on the "down titrated" group of 75 (probably s/b 72), what is the meaning of the "Subjects with no Up Titration to 30mg or 50mg"?
bas, I think Rett NDA is filed before end of Q3 and if the rolling submissions have occurred, IMO with the Ariana computer power, the data analysis of n = 92 should allow for this to occur. After which, as Dr. Oph points out, a presentation at that conference makes sense given the British/European role in the Rett trial.
Hoskuld/Other Posters, with regards to the timing of NDA's for Rett and AD, may the AD NDA for accelerated approval be filed before Rett, given that Rett is fast track, or does it have to wait until after Rett is filed?
TIA
Her's the Lilly announcement per Reuters (in case it has not been posted):
Not sure how it arrived @ 60%, given the numbers were much lower in its May report.
https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-drug-slows-alzheimers-by-60-mildly-impaired-patients-alzheimers-group-says-2023-07-17/
I only stating what TGD said @ the ASM.